John M. Gansner

2.1k total citations
28 papers, 872 citations indexed

About

John M. Gansner is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, John M. Gansner has authored 28 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Hematology. Recurrent topics in John M. Gansner's work include Kidney Stones and Urolithiasis Treatments (8 papers), Biomedical Research and Pathophysiology (5 papers) and Connective tissue disorders research (4 papers). John M. Gansner is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (8 papers), Biomedical Research and Pathophysiology (5 papers) and Connective tissue disorders research (4 papers). John M. Gansner collaborates with scholars based in United States, France and Israel. John M. Gansner's co-authors include Jonathan D. Gitlin, Richard M. Kaufman, Robert S. Makar, Stephen W. Waldo, Ayad Hamdan, Marisa B. Marques, Pavan K. Bendapudi, Lova Sun, Leonard I. Zon and Shelley Hurwitz and has published in prestigious journals such as Nature, Blood and FEBS Letters.

In The Last Decade

John M. Gansner

26 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Gansner United States 13 344 293 201 168 144 28 872
Maartje van den Biggelaar Netherlands 25 530 1.5× 472 1.6× 598 3.0× 37 0.2× 108 0.8× 79 1.6k
Jim Apostolopoulos Australia 17 258 0.8× 283 1.0× 150 0.7× 107 0.6× 65 0.5× 26 838
Yasuharu Kanki Japan 19 157 0.5× 1.1k 3.8× 72 0.4× 55 0.3× 141 1.0× 40 1.5k
Dominic J. Ciavatta United States 14 210 0.6× 526 1.8× 176 0.9× 52 0.3× 45 0.3× 23 963
Brahmananda R. Chitteti United States 20 270 0.8× 528 1.8× 507 2.5× 28 0.2× 82 0.6× 37 1.3k
Katsumi Yabusaki Japan 11 145 0.4× 296 1.0× 103 0.5× 112 0.7× 72 0.5× 22 1.0k
Todd Seeley United States 12 127 0.4× 685 2.3× 88 0.4× 42 0.3× 106 0.7× 16 1.3k
Elizabeth A. Traxler United States 10 80 0.2× 547 1.9× 424 2.1× 56 0.3× 62 0.4× 15 1.2k
Stephen T. Koury United States 20 117 0.3× 643 2.2× 518 2.6× 40 0.2× 162 1.1× 31 1.5k
Julia Huber Austria 17 228 0.7× 377 1.3× 34 0.2× 50 0.3× 61 0.4× 31 1.1k

Countries citing papers authored by John M. Gansner

Since Specialization
Citations

This map shows the geographic impact of John M. Gansner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Gansner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Gansner more than expected).

Fields of papers citing papers by John M. Gansner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Gansner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Gansner. The network helps show where John M. Gansner may publish in the future.

Co-authorship network of co-authors of John M. Gansner

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Gansner. A scholar is included among the top collaborators of John M. Gansner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Gansner. John M. Gansner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frishberg, Yaacov, Jaap W. Groothoff, Sally‐Anne Hulton, et al.. (2025). Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria. Nephrology Dialysis Transplantation. 41(3). 575–583.
2.
Sanyal, Arun J., Jörg Täubel, Prajakta Badri, et al.. (2025). Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis. Journal of Hepatology. 83(4). 838–848. 2 indexed citations
3.
Lieske, John C., Jaap W. Groothoff, Yaacov Frishberg, et al.. (2025). Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study. Kidney Medicine. 7(11). 101115–101115.
4.
Frishberg, Yaacov, Wesley Hayes, Hadas Shasha‐Lavsky, et al.. (2024). Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial. Frontiers in Pediatrics. 12. 1392644–1392644. 1 indexed citations
5.
Saland, Jeffrey M., John C. Lieske, Jaap W. Groothoff, et al.. (2024). Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial. Kidney International Reports. 9(7). 2037–2046. 7 indexed citations
6.
Lieske, John C., Daniella Magen, Hadas Shasha‐Lavsky, et al.. (2023). Lumasiran for Primary Hyperoxaluria Type 1 and Impaired Kidney Function: 24-Month Analysis of the Phase 3 ILLUMINATE-C Trial. Journal of the American Society of Nephrology. 34(11S). 566–566. 1 indexed citations
7.
Hayes, Wesley, David J. Sas, Daniella Magen, et al.. (2022). Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial. Pediatric Nephrology. 38(4). 1075–1086. 30 indexed citations
8.
Michael, Mini, Jaap W. Groothoff, Hadas Shasha‐Lavsky, et al.. (2022). Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial. American Journal of Kidney Diseases. 81(2). 145–155.e1. 50 indexed citations
9.
Magen, Daniella, J. W. Groothoff, Sally A. Hulton, et al.. (2022). POS-438 Long-term Treatment With Lumasiran: Results From the Phase 2 Open-Label Extension Study. Kidney International Reports. 7(2). S195–S195. 2 indexed citations
10.
Zhao, Jingcheng, Erin E. Gabriel, Rut Norda, et al.. (2020). Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study. Transfusion. 61(2). 464–473. 9 indexed citations
11.
Gansner, John M., et al.. (2019). Severe CD4+ T‐cell lymphopenia is not observed in frequent plateletpheresis donors collected on the Fenwal Amicus. Transfusion. 59(9). 2783–2787. 3 indexed citations
12.
Kapp, Friedrich, Julie R. Perlin, Elliott J. Hagedorn, et al.. (2018). Protection from UV light is an evolutionarily conserved feature of the haematopoietic niche. Nature. 558(7710). 445–448. 58 indexed citations
13.
Gansner, John M. & Nancy Berliner. (2018). The rheumatology/hematology interface: CAPS and MAS diagnosis and management. Hematology. 2018(1). 313–317. 7 indexed citations
14.
Gansner, John M., et al.. (2016). Transplantation in zebrafish. Methods in cell biology. 138. 629–647. 26 indexed citations
15.
Gansner, John M. & Iván O. Rosas. (2013). Telomeres in lung disease. Translational research. 162(6). 343–352. 30 indexed citations
16.
Boxtel, Antonius L. van, et al.. (2011). Lysyl oxidase-like 3b is critical for cartilage maturation during zebrafish craniofacial development. Matrix Biology. 30(3). 178–187. 20 indexed citations
17.
Gansner, John M., Erik Madsen, Robert P. Mecham, & Jonathan D. Gitlin. (2008). Essential role for fibrillin‐2 in zebrafish notochord and vascular morphogenesis. Developmental Dynamics. 237(10). 2844–2861. 33 indexed citations
18.
Gansner, John M. & Jonathan D. Gitlin. (2008). Essential role for the alpha 1 chain of type VIII collagen in Zebrafish notochord formation. Developmental Dynamics. 237(12). 3715–3726. 42 indexed citations
19.
Gansner, John M., Bryce A. Mendelsohn, Keith A. Hultman, Stephen L. Johnson, & Jonathan D. Gitlin. (2007). Essential role of lysyl oxidases in notochord development. Developmental Biology. 307(2). 202–213. 74 indexed citations
20.
Anderson, Carrie L., John M. Gansner, Duncan Wilson, et al.. (2006). Chemical genetics suggests a critical role for lysyl oxidase in zebrafish notochord morphogenesis. Molecular BioSystems. 3(1). 51–59. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maartje van den Biggelaar Breakdown of academic impact, for papers by Jim Apostolopoulos Breakdown of academic impact, for papers by Yasuharu Kanki Breakdown of academic impact, for papers by Dominic J. Ciavatta Breakdown of academic impact, for papers by Brahmananda R. Chitteti Breakdown of academic impact, for papers by Katsumi Yabusaki Breakdown of academic impact, for papers by Todd Seeley Breakdown of academic impact, for papers by Elizabeth A. Traxler Breakdown of academic impact, for papers by Stephen T. Koury Breakdown of academic impact, for papers by Julia Huber
Rankless by CCL
2026